FrancophonIA/ELRC3.0 huggingface dataset:
English: Trometamol Sodium chloride Water for injections
Danish: Natriumchlorid Vand til injektionsvæsker
English: IMVANEX suspension for injection Smallpox vaccine (Live Modified Vaccinia Virus Ankara)
Danish: IMVANEX injektionsvæske, suspension Koppevaccine (levende modificeret vaccinia virus Ankara)
English: If previously stored at -20°C +/-5°C, the vaccine can be stored short-term in a refrigerator at 2°C-8°C for up to 8 weeks prior to use.
Danish: Hvis vaccinen tidligere blev opbevaret ved -20 °C +/-5 °C, kan den kortvarigt opbevares i et køleskab ved temperaturer på 2 °C- 8 °C i op til 8 uger før brug.
English: What you need to know before you receive IMVANEX 3.
Danish: Det skal du vide, før du begynder at få IMVANEX 3.
English: Active immunisation against smallpox in adults (see sections 4.4 and 5.1).
Danish: Aktiv immunisering mod kopper hos voksne (se pkt.
English: How IMVANEX is given 4.
Danish: Sådan gives IMVANEX 4.
English: • Non-interventional post-authorisation safety study (PASS) POX-MVA-038: An observational, non-interventional postauthorisation safety study for the prophylactic vaccination with IMVANEX for [insert description of target vaccinee population]
Danish: POX-MVA-038: Et observerende, non-interventionsstudie efter markedsføring for den profylaktiske vaccination med IMVANEX til [indsæt beskrivelsen af målpopulationen af vaccinen]
English: This vaccine contains trace residues of gentamicin (see section 4.3).
Danish: Denne vaccine indeholder meget små restmængder af gentamicin (se pkt.
English: After thawing, the vaccine should be used immediately or if previously stored at -20°C +/-5°C, the vaccine can be stored at 2°C-8°C in the dark for up to 8 weeks prior to use.
Danish: Efter optøning skal vaccinen straks bruges eller hvis den tidligere blev opbevaret ved -20 °C +/-5 °C, kan vaccinen opbevares ved temperaturer på 2 °C- 8 °C i mørke i op til 8 uger før brug.
English: • nose and throat infection, upper respiratory tract infection,
Danish: • næse- og halsinfektion, infektion af de øvre luftveje,
English: • bleeding, irritation, scaling, inflammation, abnormal skin sensation, reaction at the injection iste,
Danish: • blødning, irritation, skællen, betændelse, unormal følelse i huden, reaktion på injektionsstedet,
English: Lower immune response data have been observed in HIV infected individuals compared to healthy individuals (see section 5.1).
Danish: Blandt disse blev der observeret lavere vaccinations immunrespons sammenlignet med raske personer (se pkt.
English: Some of the undesirable effects mentioned in section 4.8 may affect the ability to drive or use machines (e.g. dizziness).
Danish: 4.8 kan påvirke evnen til at føre motorkøretøj eller betjene maskiner (f.eks. svimmelhed).
English: • lump in skin,
Danish: • knude i huden
English: Day 01
Danish: Dag 01
English: 1Day 0 corresponding to day of vaccination with IMVANEX; Day 7/14 corresponding to 1 or 2 weeks after vaccination with IMVANEX (first post vaccination analysis at Day 7 in study POX-MVA-011, and at Day 14 in studies POX-MVA-005 and POX-MVA-024); Day 28 corresponding to 4 weeks after vaccination with IMVANEX; SCR = Seroconversion rate; 2 Full Analysis Set (FAS).
Danish: 1Dag 0 svarende til datoen for vaccination med IMVANEX, Dag 7/14 svarende til 1 eller 2 uger efter vaccination med IMVANEX (første post-vaccinationsanalyse ved Dag 7 i studie POX-MVA-011, og ved Dag 14 i studierne POX-MVA-005 og POX-MVA-024), Dag 28 svarende til 4 uger efter vaccination med IMVANEX, SCR = Serokonversionsrate, 2 fuldstændigt analysesæt (Full Analysis Set, FAS).
English: Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 or trace residues (chicken protein, benzonase and gentamicin).
Danish: 6.1 eller enkelte sporstoffer (kyllingeprotein, benzonase og gentamicin).
English: Nasopharyngitis Upper respiratory tract infection
Danish: Nasofaryngitis Infektion af de øvre luftveje
English: • Non-interventional post-authorisation efficacy study (PAES) POX-MVA-039: An observational, non-interventional postauthorisation safety and efficacy study for the prophylactic vaccination with IMVANEX following re-emergence of circulating smallpox infections
Danish: POX-MVA-039: Et observerende, non-interventionsstudie efter markedsføring af sikkerhed og virkning for den profylaktiske vaccination med IMVANEX efter cirkulerende koppeinfektion er dukket op igen
English: 1Day 0 corresponding to day of booster vaccination with IMVANEX (pre-booster); Day 7 and 14 corresponding to 1 or 2 weeks after booster vaccination with IMVANEX; N = number of subjects in the specific study group; ELISA = enzymelinked immunosorbent assay; PRNT = plaque reduction neutralization test; S+ = Seropositivity rate; GMT = geometric mean titre.
Danish: 1Dag 0 svarende til dagen for boostervaccinationen med IMVANEX (præ-booster), Dag 7 og 14 svarende til 1 eller 2 uger efter boostervaccination med IMVANEX, N = antal personer i den specifikke studiegruppe, ELISA = enzyme-linked immunosorbent assay, PRNT = plaque reduction neutralisation test, S+ = seropositivitetsrate, GMT = geometric mean titre (geometrisk gennemsnitstiter).
English: • weakness,
Danish: • svaghed,
English: Muscle spasms Musculoskeletal pain Muscular weakness
Danish: Muskelspasmer Smerter i knogler, led og muskler Muskelsvaghed
English: Bavarian Nordic A/S Hejreskovvej 10a DK-3490 Kvistgaard Denmark
Danish: Bavarian Nordic A/S Hejreskovvej 10a DK-3490 Kvistgaard Danmark
English: How IMVANEX is given
Danish: Sådan gives IMVANEX
English: 1Produced in chick-embryo cells
Danish: 1Fremstillet i celler fra kyllingeembryoer
English: • dizziness, abnormal skin sensations,
Danish: • svimmelhed, unormale følelser i hud,
English: Dizziness Paresthesia
Danish: Svimmelhed Paræstesi
English: Dermatitis Skin discolouration
Danish: Pruritus Dermatitis Misfarvning af hud
English: The most common adverse reactions observed in clinical trials were injection site reactions and common systemic reactions typical for vaccines which were mild to moderate in intensity and resolved without intervention within seven days following vaccination.
Danish: De mest almindelige bivirkninger der blev observeret i kliniske studier var reaktioner på injektionsstedet og almindelige systemiske reaktioner, som er typiske for vacciner.
English: • migraine,
Danish: • hovedpine,
English: • underarm swelling, feeling unwell, flushing, chest pain, pain in the armpit,
Danish: • hævelse under armen, utilpashed, rødme, brystsmerter, smerter i armhulen,
English: Bavarian Nordic A/S Hejreskovvej 10a 3490 Kvistgaard Denmark
Danish: Bavarian Nordic A/S Hejreskovvej 10a 3490 Kvistgaard Danmark
English: 2 years at -20°C +/-5°C
Danish: 2 år ved -20°C +/-5°C
English: Thaw at room temperature.
Danish: Optøs ved stuetemperatur.
English: IMVANEX suspension for injection Smallpox vaccine
Danish: IMVANEX injektionsvæske, suspension Koppevaccine
English: • if you have previously had a sudden life-threatening allergic reaction to any ingredient of Imvanex (these are listed in section 6) or chicken protein, benzonase or gentamicin which may be present in the vaccine in very small amounts.
Danish: 6) eller kyllingeprotein, benzonase eller gentamicin, der kan findes i vaccinen i meget små mængder.
English: • loss of appetite,
Danish: • appetitløshed,
English: • faster heart beat,
Danish: • hurtigere puls,
English: Store in a freezer (at -20°C +/-5°C or -50°C +/-10°C or -80°C +/-10°C) protected from light.
Danish: Opbevares i dybfryser (ved -20°C +/-5°C eller -50°C +/-10°C eller -80°C +/-10°C) beskyttet mod lys.
English: Rare (may affect up to 1 in 1000 people):
Danish: Sjælden (kan forekomme hos op til 1 ud af 1.000 personer):
English: 5 years at -50°C +/-10°C
Danish: 5 år ved -50°C +/-10°C
English: • diarrhoea, vomiting, abdominal pain, dry mouth,
Danish: • diarré, opkastning, mavesmerter, mundtørhed,
English: 5 years at -80°C +/-10°C
Danish: 5 år ved -80°C +/-10°C
English: • swollen lymph nodes,
Danish: • hævede lymfeknuder,
English: • drowsiness,
Danish: • træthed,
English: White blood cell count decreased Mean platelet volume decreased
Danish: nedsat eller forhøjet antal hvide blodlegemer, nedsat gennemsnitligt antal blodplader,
English: • rash, numbness, dryness, movement impairment, vesicles at the injection site,
Danish: • udslæt, følelsesløshed, tørhed, nedsat bevægelighed, vesikler på injektionsstedet,
English: • increase of cardiac laboratory values (like Troponin I ), liver enzyme increased, white blood cell count decreased, mean platelet volume decreased
Danish: • forhøjelse af laboratorieprøver for hjertemarkører (såsom troponin I), forhøjede leverenzymer,
English: 1Day 7/14 corresponding to 1 or 2 weeks after the first IMVANEX dose (analysis time point at Day 7 only in studies POXMVA-008 and POX-MVA-011; POX-MVA-005 had the first post vaccination analysis at Day 14); Day 28 corresponding to 4 weeks after the first IMVANEX dose; Day 42 corresponding to 2 weeks following the second dose of IMVANEX;
Danish: 1Dag 7/14 svarende til 1 eller 2 uger efter den første IMVANEX-dosis (analysetidspunkt ved Dag 7 kun i studierne POXMVA-008 og POX-MVA-011; POX-MVA-005 havde den første post-vaccinationsanalyse ved Dag 14), Dag 28 svarende til 4 uger efter den første IMVANEX-dosis, Dag 42 svarende til 2 uger efter den anden dosis IMVANEX; SCR = Serokonversionsrate, 2 fuldstændigt analysesæt (Full Analysis Set, FAS) (for POX-MVA-013: Immunogenicitetsanalysesæt, IAS), 3 pr. protokol analysesæt (Per Protocol Analysis Set, PPS), 4 seropositivitetsrater, 5 ingen immunogenicitetsprøver blev taget, 6 kombinerede grupper 1-3.
English: Injection site haemorrhage Injection site irritation Flushing
Danish: Utilpashed Blødning på injektionsstedet Irritation på injektionsstedet Rødme
English: Store in a freezer (at -20°C +/-5°C or -50°C +/-10°C or -80°C +/-10°C).
Danish: Opbevares i dybfryser (ved -20°C +/-5°C eller -50°C +/-10°C eller -80°C +/-10°C).
English: • rash, itch, skin inflammation, skin discolouration,
Danish: • udslæt, kløe, hudbetændelse, misfarvning af hud,
English: • influenza like illness,
Danish: • influenzalignende sygdom,
English: • lump, discolouration, bruising or warmth at the injection site.
Danish: • en knude, misfarvning, blå mærker eller varme på injektionsstedet.
English: ELISA S+ % GMT
Danish: Dag 141 ELISA S+ % GMT S+ % GMT S+ % GMT
English: • aching muscles,
Danish: • smertende muskler,
English: Month N SCR % (95% CI)
Danish: Måned N SCR % (95% CI)
English: • tiredness,
Danish: • svedtendens,
English: Rigor/Chills Injection site nodule Injection site discolouration Injection site haematoma Injection site warmth
Danish: Stivhed/kulderystelser Knuder på injektionsstedet Misfarvning på injektionsstedet Hæmatom på injektionsstedet Varme på injektionsstedet
English: • pain, redness, swelling, hardness or itching at the injection site.
Danish: • smerter, rødme, hævelse, hærdning eller kløe på injektionsstedet.
English: Study status N SCR % SCR % (95% CI)
Danish: Helbredsstatus N SCR % SCR % (95% CI)
English: Do not refreeze the vaccine once thawed.
Danish: Vaccinen må ikke fryses igen, efter den er optøet.
English: Injection site inflammation Injection site paraesthesia Injection site reaction movement impairment Influenza like illness Injection site vesicles
Danish: Eksfoliation på injektionsstedet Betændelse på injektionsstedet Paræstesi på injektionsstedet Reaktion på injektionsstedet
English: • muscle pain,
Danish: • muskelkramper,
English: AD 257 5.6 (3.1, 9.3)
Danish: (63,0; 76,1) Ikke relevant
English: Injection site dryness Injection site
Danish: Vesikler på injektionsstedet
English: • muscle weakness,
Danish: • muskelsmerter,
English: N/A5
Danish: Ikke relevant5
English: • sore throat, runny nose, cough,
Danish: • ondt i halsen, næseflåd, hoste,
English: Diarrhoea Vomiting Abdominal Pain Dry mouth
Danish: Opkastning Mavesmerter Mundtørhed
English: • skin bruising,
Danish: • nældefeber,
English: • night sweats,
Danish: • nattesved,
English: • muscle stiffness, back pain, neck pain,
Danish: • muskelstivhed, rygsmerter, nakkesmerter,
English: Musculoskeletal stiffness Back pain Neck pain
Danish: Brystsmerter Aksillære smerter
English: • feeling sick,
Danish: • kvalme,
English: • joint pain, pain in extremities,
Danish: • ledsmerter, smerter i arme og ben,
English: Optruma should not be used in women who:
Danish: Optruma bør ikke anvendes af kvinder, som:
English: Other information about Optruma:
Danish: Andre oplysninger om Optruma:
English: The European Commission granted a marketing authorisation valid throughout the European Union for Optruma to Eli Lilly Nederland B.V. on 5 August 1998.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Optruma til Eli Lilly Nederland B.V.
English: The Committee recommended that Optruma be given marketing authorisation.
Danish: Udvalget anbefalede udstedelse af markedsføringstilladelse for Optruma.
English: It is available as white, oval tablets (60 mg).
Danish: Det fås som hvide ovale tabletter (60 mg).
English: The full EPAR for Optruma is available here.
Danish: Den fuldstændige EPAR for Optruma findes her.
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) OPTRUMA EPAR summary for the public
Danish: EUROPÆISK OFFENTLIG VURDERINGSRAPPORT (EPAR) OPTRUMA EPAR - sammendrag for offentligheden
English: Optruma should not be used in people who may be hypersensitive (allergic) to raloxifene or any of the other ingredients.
Danish: Optruma bør ikke anvendes hos personer, som kan være overfølsomme (allergiske) over for raloxifen eller et af de øvrige indholdsstoffer.
English: Optruma is a medicine containing the active substance raloxifene hydrochloride.
Danish: Optruma er et lægemiddel, der indeholder det aktive stof raloxifenhydrochlorid.
English: The main measure of effectiveness was how many women had vertebral (spine) fractures during the study.
Danish: Den vigtigste målestok for virkningen var, hvor mange kvinder der havde vertebrale frakturer (rygsøjlen) i løbet af undersøgelsen.
English: There was no effect of Optruma on hip fractures.
Danish: Der var ingen effekt af Optruma på hoftefrakturer.
English: The most common side effects with Optruma (seen in more than 1 patient in 10) are vasodilation (hot flushes) and flu-like symptoms.
Danish: De hyppigste bivirkninger ved Optruma (som ses hos flere end 1 ud af 10 patienter) er vasodilation (hedestigninger) og influenzalignende symptomer.
English: Patients may also receive calcium and vitamin D supplements if they do not get enough from their diet. Optruma is intended for long-term use.
Danish: Patienterne kan også få calcium- og vitamin D-tilskud, hvis de ikke får tilstrækkeligt gennem deres kost.
English: What is the risk associated with Optruma?
Danish: Hvilken risiko er der forbundet med Optruma?
English: The active substance in Optruma, raloxifene, is a selective oestrogen receptor modulator (SERM).
Danish: Det aktive stof i Optruma, raloxifen, er en selektiv østrogen receptor modulator (SERM).
English: The fourth study compared the effects of Optruma with those of placebo in the treatment of osteoporosis in 7,705 women over four years.
Danish: I den fjerde undersøgelse sammenlignede man effekten af Optruma med effekten af placebo til behandling af osteoporose hos 7 705 kvinder over fire år.
English: Optruma has been shown to significantly reduce vertebral fractures (breaks in the spine), but not hip fractures.
Danish: Det er påvist, at Optruma i væsentlig grad begrænser forekomsten af vertebrale frakturer (brud på rygsøjlen), men ikke hoftefrakturer.
English: Over four years, in comparison with placebo, Optruma decreased the number of new vertebral fractures by 46% in women who had osteoporosis and by 32% in women who had osteoporosis and an existing fracture.
Danish: Sammenlignet med placebo nedsatte Optruma over 4 år hyppigheden af nye vertebrale frakturer med 46 % hos kvinder, som havde osteoporose, og med 32 % hos kvinder, som havde osteoporose og en eksisterende fraktur.
English: Optruma is used for the treatment and prevention of osteoporosis (a disease that makes bones fragile) in women who have been through the menopause.
Danish: Optruma anvendes til behandling og forebyggelse af osteoporose (en sygdom, der gør knoglerne skøre) hos kvinder, der har været gennem overgangsalderen.
English: Three studies looked at the prevention of osteoporosis in 1,764 women, who took either Optruma or placebo (a dummy treatment) for two years.
Danish: I tre undersøgelser undersøgte man forebyggelse af osteoporose hos 1 764 kvinder, som fik enten Optruma eller placebo (en uvirksomhed behandling) i to år.
English: The Committee decided that Optruma's benefits are greater than its risks for the treatment and prevention of osteoporosis in postmenopausal women.
Danish: Udvalget besluttede, at fordelene ved Optruma er større end risiciene ved behandling og forebyggelse af osteoporose hos postmenopausale kvinder.
English: Why has Optruma been approved?
Danish: Hvorfor blev Optruma godkendt?
English: For the full list of side effects reported with Optruma, see the Package Leaflet.
Danish: Den fuldstændige liste over de indberettede bivirkninger for Optruma fremgår af indlægssedlen.
English: The Committee for Medicinal Products for Human Use (CHMP) concluded that Optruma had shown its effectiveness in preventing and treating osteoporosis, and had no effects on the breast or womb.
Danish: Udvalget for Humanmedicinske Lægemidler (CHMP) konkluderede, at Optruma havde vist sig at være virksomt til forebyggelse og behandling af osteoporose, og at det ikke havde nogen indvirkning på bryst og livmoder.
English: What benefit has Optruma shown during the studies?
Danish: Hvilken fordel viser undersøgelserne, der er ved Optruma?
English: When used to treat osteoporosis, Optruma was more effective than placebo in reducing the number of vertebral fractures.
Danish: Til behandling af osteoporose var Optruma mere effektivt end placebo til at reducere antallet af vertebrale frakturer.
English: Optruma was more effective than placebo in preventing and treating osteoporosis.
Danish: Optruma var mere effektiv end placebo til at forebygge og behandle osteoporose.
English: In the prevention of osteoporosis, women receiving Optruma had an increase in bone density in the hip or spine of 1.6% over two years, and those receiving placebo had a decrease of 0.8%.
Danish: Med hensyn til forebyggelse af osteoporose havde kvinder, som fik Optruma, en stigning i knogletætheden i hoften eller rygsøjlen på 1,6 % over to år, og dem, der fik placebo, havde et fald på
English: What is Optruma?
Danish: Hvad er Optruma?
English: What is Optruma used for?
Danish: Hvad anvendes Optruma til?
English: Optruma has been studied in the treatment and in the prevention of osteoporosis in four main studies.
Danish: Optruma blev undersøgt i fire hovedundersøgelser til behandling og forebyggelse af osteoporose.
English: How has Optruma been studied?
Danish: Hvordan blev Optruma undersøgt?
English: How is Optruma used?
Danish: Hvordan anvendes Optruma?
English: How does Optruma work?
Danish: Hvordan virker Optruma?
English: Avaglim is taken once a day, just before or during a meal, generally breakfast.
Danish: Avaglim tages en gang dagligt lige inden eller under et måltid, generelt morgenmaden.
English: This document is a summary of the European Public Assessment Report (EPAR) for Avaglim.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Avaglim.
English: The European Commission granted a marketing authorisation valid throughout the EU for Avaglim to Smithkline Beecham Ltd. on 27 June 2006.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Avaglim til Smithkline Beecham Ltd. den 27. juni 2006.
English: Rosiglitazone has been authorised in the European Union (EU) as Avandia since 2000.
Danish: Rosiglitazon har været godkendt i Den Europæiske Union (EU) under navnet Avandia siden 2000.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of
Danish: Det forklarer, hvordan Udvalget for Lægemidler til Mennesker (CHMP) vurderede lægemidlet og nåede frem til sin udtalelse til fordel for udstedelse af en markedsføringstilladelse og til sine anbefalinger om
English: It is available as triangular tablets (pink: 4 mg rosiglitazone and 4 mg glimepiride; red: 8 mg rosiglitazone and 4 mg
Danish: Det fås som trekantede tabletter (lyserøde: 4 mg rosiglitazon og 4 mg glimepirid; røde: 8 mg rosiglitazon og 4 mg
English: Why has Avaglim been approved?
Danish: Hvorfor blev Avaglim godkendt?
English: Avaglim is used to treat adults who have type 2 diabetes.
Danish: Avaglim anvendes til behandling af voksne med type 2-diabetes.
English: As a result of the action of both active substances, the blood glucose is reduced and this helps to
Danish: Som resultat af virkningen af begge de aktive stoffer sænkes blodglukosen, og dette medvirker til at
English: The dose can be increased to the 8-mg/4-mg tablets after eight weeks if needed, but this should be done with caution, due to the risk of fluid retention.
Danish: Den kan dernæst øges til 8 mg/4 mg tabletter efter otte uger om nødvendigt, men der bør udvises forsigtighed på grund af risikoen for væskeansamlinger.
English: The full EPAR for Avaglim can be found here.
Danish: Den fuldstændige EPAR for Avaglim kan ses her.
English: In all four studies, the combination of rosiglitazone and glimepiride was shown to be more effective than either of its components used on its own in lowering the levels of HbA1c.
Danish: I alle fire undersøgelser viste kombinationen af rosiglitazon og glimepirid sig at være mere effektiv end hver af dets komponenter anvendt alene til sænkning af niveauerne af HbA1c.
English: In addition, four studies were carried out, comparing the combination of both active substances to each substance on its own, in patients who had never been treated, as well as in patients whose blood glucose levels were not controlled when treated with only one of the substances.
Danish: Endvidere blev der også gennemført fire undersøgelser, hvori man sammenlignede en kombination af begge aktive stoffer med hvert enkelt stof alene hos patienter, som aldrig var blevet behandlet, og patienter, hvis blodsukkerniveauer ikke var under kontrol, når de blev behandlet med kun et af stofferne.
English: It can be used in combination with a sulphonylurea when metformin is not suitable.
Danish: Det kan anvendes i kombination med et sulfonylurinstof, når metformin ikke er egnet.
English: For more information about treatment with Avaglim, read the Package Leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Avaglim, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit
English: 4-mg/4-mg tablet.
Danish: Doseringen indledes med en 4 mg/4 mg tablet.
English: If the patient develops hypoglycaemia, then a return to separate tablets will be needed so that the dose of glimepiride can be adjusted.
Danish: Hvis patienten udvikler hypoglykæmi, er det nødvendigt at vende tilbage til særskilte tabletter, så doseringen af glimepirid kan justeres.
English: Avaglim contains two active substances, which have different modes of action:
Danish: Avaglim indeholder to aktive stoffer, som virker forskelligt:
English: Glimepiride has been available in
Danish: Glimepirid har været
English: • glimepiride is a sulphonylurea: it stimulates the pancreas to produce more insulin.
Danish: • Glimepirid er et sulfonylurinstof: det stimulerer bugspytkirtlen til at producere mere insulin.
English: The studies measured the level in the blood of a substance called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
Danish: I undersøgelserne måltes niveauet i blodet af et stof kaldet glykosyleret hæmoglobin (HbA1c), som viser, hvor godt blodsukkeret er reguleret.